⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23883124 | 1.00 | — | — | |
| SCHEMBL22589402 | 0.75 | NOS3 (0.36) | — | |
| SCHEMBL1708937 | 0.75 | — | — | |
| SCHEMBL2933677 | 0.75 | — | — | |
| SCHEMBL2222898 | 0.75 | — | — | |
| Hydrochloric Acid SCHEMBL4419382 | 0.73 | — | — | |
| Hydrochloric Acid SCHEMBL11107945 | 0.73 | NOS3 (0.35) | — | |
| SCHEMBL6154815 | 0.73 | — | — | |
| SCHEMBL7360709 | 0.73 | — | — | |
| Hydrochloric Acid SCHEMBL9034919 | 0.73 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023194412-A1 | SIRNA TARGETING KCNA1 | FONDO RICERCA MEDICA S.R.L. (IT) | 2023-10-12 | — | — | WO | claimed |
| EP-3145553-B1 | SMALL INTERFERING RNA (SIRNA) FOR THE THERAPY OF TYPE 2 (ADO2) AUTOSOMAL DOMINANT OSTEOPETROSIS CAUSED BY CLCN7 (ADO2 CLCN7-DEPENDENT) GENE MUTATION | UNIV DEGLI STUDI DELLAQUILA (IT) | 2019-07-31 | — | — | EP | claimed |
| EP-3145553-A1 | SMALL INTERFERING RNA (SIRNA) FOR THE THERAPY OF TYPE 2 (ADO2) AUTOSOMAL DOMINANT OSTEOPETROSIS CAUSED BY CLCN7 (ADO2 CLCN7-DEPENDENT) GENE MUTATION | Universita' Degli Studi Dell'Aquila (IT) | 2017-03-29 | — | — | EP | claimed |
| WO-2015177743-A1 | SMALL INTERFERING RNA (SIRNA) FOR THE THERAPY OF TYPE 2 (ADO2) AUTOSOMAL DOMINANT OSTEOPETROSIS CAUSED BY CLCN7 (ADO2 CLCN7-DEPENDENT) GENE MUTATION | UNIVERSITÀ DEGLI STUDI DELL'AQUILA (IT) | 2015-11-26 | — | — | WO | claimed |
| EP-4398254-A2 | COMPOSITIONS AND METHODS FOR ALTERING SECOND MESSENGER SIGNALING | Memorial Sloan Kettering Cancer Center (US) | 2024-07-10 | — | — | EP | disclosed |
| US-20240132628-A1 | OLIGONUCLEOTIDE ANALOGUE THERAPEUTICS FOR TREATMENT OF NEUROMUSCULAR DISEASE | NEUBASE THERAPEUTICS, INC. | 2024-04-25 | — | — | US | disclosed |
| EP-2991655-B1 | COMPOSITIONS AND METHODS FOR ALTERING SECOND MESSENGER SIGNALING | MEMORIAL SLOAN KETTERING CANCER CENTER (US) | 2024-04-10 | — | — | EP | disclosed |
| EP-4288536-A1 | SMALL INTERFERING RNA (SIRNA) FOR THERAPY OF MMIHS CAUSED BY ACTG2 GENE MUTATION | Dante Labs S.r.l. (IT) | 2023-12-13 | — | — | EP | disclosed |
| WO-2023233159-A1 | THERAPEUTIC COMPOUNDS AND COMPOSITIONS | SISAF LTD (GB) | 2023-12-07 | — | — | WO | disclosed |
| WO-2023194412-A1 | SIRNA TARGETING KCNA1 | FONDO RICERCA MEDICA S.R.L. (IT) | 2023-10-12 | — | — | WO | disclosed |
| US-20230174985-A1 | MODIFIED PEPTIDE NUCLEIC ACID COMPOSITIONS | NEUBASE THERAPEUTICS, INC. | 2023-06-08 | — | — | US | disclosed |
| US-11603530-B2 | Modified peptide nucleic acid compositions | NEUBASE THERAPEUTICS, INC. (US) | 2023-03-14 | — | — | US | disclosed |
| CN-102216462-A | Branched Cationic Lipids for Nucleic Acid Delivery Systems | ENZON PHARMACEUTICALS INC | 2011-10-12 | — | — | CN | disclosed |
| CN-102215820-A | Releasable Fusogenic Lipids for Nucleic Acid Delivery Systems | ENZON PHARMACEUTICALS INC | 2011-10-12 | — | — | CN | disclosed |
| US-6911554-B2 | Isocyano substituted polystyrene carbonate resin for use in 3 and 4 component condensation reactions | ARRAY BIOPHARMA INC. (US) | 2005-06-28 | — | — | US | disclosed |
| US-20030225267-A1 | Isocyano substituted polystyrene carbonate resin for use in 3 and 4 component condensation reactions | ARRAY BIOPHARMA INC. | 2003-12-04 | — | — | US | disclosed |
| US-6114328-A | ANTICOAGULANTS; BLOOD DISORDERS | DUPONT PHARMACEUTICALS COMPANY (US) | 2000-09-05 | — | — | US | disclosed |
| US-5817751-A | IMMOBILIZATION AN AMINOACID ON SUPPORT; CYCLIZATION | AFFYMAX TECHNOLOGIES N.V. (GB) | 1998-10-06 | — | — | US | disclosed |
| WO-1996000391-A1 | METHODS FOR THE SYNTHESIS OF DIKETOPIPERAZINES | AFFYMAX TECHNOLOGIES N.V. (AN) | 1996-01-04 | — | — | WO | disclosed |
| US-4134918-A | ENZYME INHIBITORS, ANTIBODY INHIBITORS | MERRELL TORAUDE ET COMPAGNIE (FR) | 1979-01-16 | — | — | US | disclosed |